TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder ...

Your bladder relies on muscles to contract and release when you’re ready to urinate. Your brain typically regulates this process, but sometimes the message that you need to urinate isn’t sent ...

The FDA recently approved a new drug application for Gemtesa, a novel treatment for overactive bladder in adults, its manufacturer announced in a press release. Gemtesa (vibegron, Urovant Sciences ...

Treatment with cretostimogene monotherapy continues to demonstrate best-in-class durability of response and consistent safety and efficacy in patients with high-risk, Bacillus Calmette-Guérin ...

Electrical stimulation of bladder strips caused acetylcholine release that could be inhibited by tetrodotoxin, suggesting the release was neuronal in origin.

EchoNous announces the release of EchoNous Bladder™, a highly reliable, all-electronic, non-mechanical, bladder scanning tool for nurses.

Urothelial receptor and/or ion channel expression and the release of signalling molecules (such as ATP and nitric oxide) can be altered with bladder disease, neural injury, target organ ...